NCT05031871 - Pharmacokinetics of HR17031 Injection in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 2, 2021

Primary Completion Date

November 19, 2021

Study Completion Date

November 19, 2021

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

HR17031 injection ；INS068 injection；SHR20004 injection

HR17031 injection dose+INS068 injection dose+SHR20004 injection dose+(INS068+SHR20004) injection dose

DRUG

HR17031 injection ；INS068 injection；SHR20004 injection

INS068 injection dose+(INS068+SHR20004)injection dose+ HR17031 injection dose +SHR20004 injection dose

DRUG

HR17031 injection ；INS068 injection；SHR20004 injection

SHR20004 injection dose+ HR17031 injection dose +(INS 068+SHR20004) injection dose+ INS068 injection dose

DRUG

HR17031 injection ；INS068 injection；SHR20004 injection

(INS 068+SHR20004) injection dose+ SHR20004 injection dose+ INS068 injection dose+ HR17031 injection dose

Trial Locations (1)

Shanghai General Hospital, Shanghai

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY